Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience
Vincenza Caputo, Vincenzo De Falco, Anna Ventriglia, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14, pp. 175883592210968-175883592210968
Open Access | Times Cited: 23

Showing 23 citing articles:

Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer
Vincenza Caputo, Fortunato Ciardiello, Carminia M. Della Corte, et al.
Exploration of Targeted Anti-tumor Therapy (2023), pp. 102-138
Open Access | Times Cited: 39
Panitumumab Plus Trifluridine-Tipiracil as Anti–Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer
Stefania Napolitano, Vincenzo De Falco, Giulia Martini, et al.
JAMA Oncology (2023) Vol. 9, Iss. 7, pp. 966-966
Open Access | Times Cited: 30
The role of anti-EGFR rechallenge in metastatic colorectal cancer, from available data to future developments: A systematic review
Davide Ciardiello, Gianluca Mauri, Andrea Sartore‐Bianchi, et al.
Cancer Treatment Reviews (2024) Vol. 124, pp. 102683-102683
Closed Access | Times Cited: 9
CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated RAS/BRAF Wild-Type mCRC Patients
Stefania Napolitano, Giulia Martini, Davide Ciardiello, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 27
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study
Marco Sposito, Lorenzo Belluomini, Riccardo Nocini, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer
Óscar Rapado‐González, Ana María Rodríguez-Ces, Rafael López‐López, et al.
Japanese Dental Science Review (2023) Vol. 59, pp. 289-302
Open Access | Times Cited: 10
Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center’s real-world approach
Eleonora Cioli, Gabriella Suarato, Rossella Napolitano, et al.
ESMO Real World Data and Digital Oncology (2025) Vol. 7, pp. 100108-100108
Closed Access
Analytical Validation of the Labcorp Plasma Complete Test, a Cell-free DNA Comprehensive Genomic Profiling Tool for Precision Oncology
Ellen L. Verner, Jennifer Jackson, Cynthia Maddox, et al.
Journal of Molecular Diagnostics (2025)
Open Access
Advancing Veterinary Oncology: Next-Generation Diagnostics for Early Cancer Detection and Clinical Implementation
Aya Hasan Alshammari, Takuya Oshiro, Umbhorn Ungkulpasvich, et al.
Animals (2025) Vol. 15, Iss. 3, pp. 389-389
Open Access
Primary exploration of cell-free DNA in the plasma of patients with parathyroid neoplasms using next-generation sequencing
Qingyuan Zheng, Ming Cui, Ou Wang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial
D. Ciardiello, Luca Boscolo Bielo, Stefania Napolitano, et al.
ESMO Open (2025) Vol. 10, Iss. 4, pp. 104511-104511
Closed Access
Circulating tumor DNA in colorectal cancer: biology, methods and applications
Han Chen, Yang An, Chentong Wang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Next-generation sequencing in cancer diagnosis and treatment: clinical applications and future directions
Nima Ghoreyshi, Reza Heidari, Arezoo Farhadi, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Biomarker validation: challenges and regulatory perspectives
Bindiya Chauhan, Bhuvnesh Kumar Singh, Tuhin James Paul, et al.
Elsevier eBooks (2025), pp. 149-176
Closed Access
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF wild type metastatic colorectal cancer in the CAPRI 2-GOIM trial
D. Ciardiello, Luca Boscolo Bielo, S. Napolitano, et al.
Annals of Oncology (2024)
Closed Access | Times Cited: 3
Comprehensive genomic profiling in multiple cancer types: A comparative analysis of the National Biobank Consortium of Taiwan and clinical practice cohorts
Ling-Jen Hung, Chen‐Yang Huang, Kai-Che Tung, et al.
Journal of the Formosan Medical Association (2024)
Open Access | Times Cited: 1
Liquid and Tissue Biopsies for Lung Cancer: Algorithms and Perspectives
Paul Hofman
Cancers (2024) Vol. 16, Iss. 19, pp. 3340-3340
Open Access | Times Cited: 1
Performance Characteristics of Oncomine Focus Assay for Theranostic Analysis of Solid Tumors, A (21-Months) Real-Life Study
Jessica Bamba‐Funck, Emmanuelle Fabre, Marianne Kambouchner, et al.
Diagnostics (2023) Vol. 13, Iss. 5, pp. 937-937
Open Access | Times Cited: 3
Circulating tumor DNA in patients with locally advanced rectal cancer treated with multimodal treatment
Lorenzo Gervaso, Davide Ciardiello, Giuliana Gregato, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Precision medicine in cancer treatment: Revolutionizing care through proteomics, genomics, and personalized therapies
Riddhi Jawdekar, Vaishnavi Mishra, Kajal Hatgoankar, et al.
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 6, pp. 1687-1693
Open Access
Panitumumab plus trifluridine/tipiracil as anti-Epidermal Growth Factor Receptor rechallenge therapy in chemo-refractory RAS wild-type metastatic colorectal cancer: the randomized phase 2 VELO trial
Fortunato Ciardiello, Teresa Troiani, Stefania Napolitano, et al.
Research Square (Research Square) (2022)
Open Access
Comprehensive Genomic Profiling of Cell-Free Circulating Tumor DNA Detects Response to Ribociclib Plus Letrozole in a Patient with Metastatic Breast Cancer
Catarina Silveira, Ana Carla Sousa, Patrícia Corredeira, et al.
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1818-1818
Open Access
Biopsi cair pada kanker kolorektal: Harapan dan tantangan
Rebecca Noerjani Angka, Demak Lumban Tobing, Aru Wisaksono Sudoyo, et al.
Damianus Journal of Medicine (2022) Vol. 21, Iss. 3, pp. 275-283
Open Access
Page 1

Scroll to top